Funding Received
$23.5 Million in 3 Rounds from 2 Investors
Most Recent Funding
$7.7 Million Series B on September 4, 2013
Headquarters:
Geneva
Description:
Mind-NRG develops peptidic neurotrophic factors for psychiatric and neurologic diseases.
Categories:
Biotechnology
Website:
http://www.mind-nrg.com

Company Details

Update

Mind-NRG (www.mind-nrg.com), a Switzerland-based company focused on the development of a peptidic neurotrophic factor (NRG-101) with disease modifying potential that crosses the blood-brain barrier by a receptor-mediated transport to reach its target.

Funding Rounds (3) - $23.5M

Update

Investors (2)

Update
  • Cb default image
  • 4b8cb82cceb342829beea060f74f8ad3

    Index Ventures

    Index Ventures is a multi-stage international venture capital firm with deep sector expertise...

Offices/Locations (1)

Update
  • Office

    Rue de Jargonnant 2

    Geneva, CH-1207

    CHE

Images (1)

Update
  • 5e3efe1cb91ef3cf185133e1fc074eea